Just like the rest of evolution in Mother Nature, the evolution of cancers may be driven by natural selection, and not by haphazard mutations
暂无分享,去创建一个
Xiaomin Lou | D. Joshua Liao | Siqi Liu | Ningzhi Xu | Siqi Liu | N. Xu | Lucas Zellmer | D. Liao | Xiaomin Lou | Lucas Zellmer | Ju Zhang | Ju Zhang
[1] H. Burrows. Carcinoma mammae occurring in a male mouse under continued treatment with oestrin. , 1935, The American journal of cancer.
[2] J. Jonkers,et al. Molecular Pathways Molecular Pathways : How Can BRCA-Mutated Tumors Become Resistant to PARP Inhibitors ? , 2014 .
[3] Andrew M. K. Brown,et al. Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer , 2013, Science.
[4] S. Subramanian,et al. Significance of Population Size on the Fixation of Nonsynonymous Mutations in Genes Under Varying Levels of Selection Pressure , 2013, Genetics.
[5] J. Platt,et al. Biological implications of cell fusion , 2005, Nature Reviews Molecular Cell Biology.
[6] C. Sonnenschein,et al. Paradoxes in Carcinogenesis: There Is Light at the End of That Tunnel! , 2013, Disruptive science and technology.
[7] C. Sonnenschein,et al. The aging of the 2000 and 2011 Hallmarks of Cancer reviews: A critique , 2013, Journal of Biosciences.
[8] C. Hartman,et al. Tumors of the breast related to the oestrin hormone. , 1934, The American journal of cancer.
[9] J. Huxley. CANCER BIOLOGY: COMPARATIVE and GENETIC * , 1956 .
[10] M. Blagosklonny. Oncogenic resistance to growth-limiting conditions , 2002, Nature Reviews Cancer.
[11] R. Noble,et al. Mammary tumors of the rat: a review. , 1959, Cancer research.
[12] P. J. Pretorius,et al. Point mutation instability (PIN) mutator phenotype as model for true back mutations seen in hereditary tyrosinemia type 1 – a hypothesis , 2012, Journal of Inherited Metabolic Disease.
[13] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[14] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[15] Daniel Birnbaum,et al. A cell cycle hypothesis of cooperative oncogenesis (Review). , 2007, International journal of oncology.
[16] Peter Bouwman,et al. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance , 2012, Nature Reviews Cancer.
[17] D. Goldenberg. Horizontal transmission of malignancy by cell–cell fusion , 2012, Expert opinion on biological therapy.
[18] B. Anokhin,et al. Naturally occurring tumours in the basal metazoan Hydra , 2014, Nature Communications.
[19] T. Ried,et al. Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo , 2012, International journal of cancer.
[20] J. Pawelek. Fusion of bone marrow-derived cells with cancer cells: metastasis as a secondary disease in cancer , 2014, Chinese journal of cancer.
[21] Carlos Sonnenschein,et al. One hundred years of somatic mutation theory of carcinogenesis: Is it time to switch? , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.
[22] Siqi Liu,et al. Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptions , 2014, Oncoscience.
[23] S. Gestl,et al. Tumor cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers , 2014, Nature.
[24] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[25] Prakash Kulkarni,et al. Competing views on cancer , 2014, Journal of Biosciences.
[26] R. Prehn,et al. A new kink in an old theory of carcinogenesis , 2013, Theoretical Biology and Medical Modelling.
[27] Jouni Uitto,et al. Revertant mosaicism in skin: natural gene therapy. , 2011, Trends in molecular medicine.
[28] J. Mallet. Hybrid speciation , 2007, Nature.
[29] P. Khavari,et al. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis , 2002, Nature Medicine.
[30] Alan Ashworth,et al. Drug resistance caused by reversion mutation. , 2008, Cancer research.
[31] T. Jacks,et al. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. , 2006, Cancer research.
[32] S. Otto,et al. Condition‐Dependent Sex and the Rate of Adaptation , 2009, The American Naturalist.
[33] R. Prehn,et al. Is an immune reaction required for malignant transformation and cancer growth? , 2012, Cancer Immunology, Immunotherapy.
[34] M. Blagosklonny. NCI's provocative questions on cancer: some answers to ignite discussion , 2011, Oncotarget.
[35] A. Knudson,et al. A continuum model for tumour suppression , 2011, Nature.
[36] Christopher G. Wilson,et al. Spatial and temporal escape from fungal parasitism in natural communities of anciently asexual bdelloid rotifers , 2013, Proceedings of the Royal Society B: Biological Sciences.
[37] T. Tsang,et al. A stem cell fusion model of carcinogenesis. , 2005, Journal of experimental therapeutics & oncology.
[38] R. Weinberg. Coming Full Circle—From Endless Complexity to Simplicity and Back Again , 2014, Cell.
[39] K. Pienta,et al. Evolution of cooperation among tumor cells , 2006, Proceedings of the National Academy of Sciences.
[40] M. Blagosklonny. Cell Immortality and Hallmarks of Cancer , 2003, Cell cycle.
[41] Dean W. Felsher,et al. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation , 2007, Proceedings of the National Academy of Sciences.
[42] A. Chakraborty,et al. Leukocyte-cancer cell fusion: initiator of the warburg effect in malignancy? , 2011, Advances in experimental medicine and biology.
[43] T. Rando,et al. The mortal strand hypothesis: non-random chromosome inheritance and the biased segregation of damaged DNA. , 2013, Seminars in cell & developmental biology.
[44] H. Heng,et al. The evolutionary mechanism of cancer , 2010, Journal of cellular biochemistry.
[45] K. Polyak,et al. Cancer: Clonal cooperation , 2014, Nature.
[46] S. Subramanian. Fixation of deleterious mutations at critical positions in human proteins. , 2011, Molecular biology and evolution.
[47] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[48] C. Lively,et al. Exposure to parasites increases promiscuity in a freshwater snail , 2014, Biology Letters.
[49] K. Young,et al. Incorporating pathologists' criteria of malignancy into the evolutionary model for cancer development , 2004, Journal of cellular biochemistry.
[50] A. Knudson,et al. Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.
[51] M. Goddard,et al. Sex enhances adaptation by unlinking beneficial from detrimental mutations in experimental yeast populations , 2012, BMC Evolutionary Biology.
[52] M. Wong,et al. Genetic basis of cell-cell fusion mechanisms. , 2013, Trends in genetics : TIG.
[53] R. Dickson,et al. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[54] E. Pennisi. Genomics. ENCODE project writes eulogy for junk DNA. , 2012, Science.
[55] D. Peeper,et al. The essence of senescence. , 2010, Genes & development.
[56] Siqi Liu,et al. The other side of the coin: The tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND–CDK4/6–RB axis , 2014, Cell cycle.
[57] Paulo P. Amaral,et al. The Reality of Pervasive Transcription , 2011, PLoS biology.
[58] A. Gudkov,et al. Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin , 2011, PloS one.
[59] John Cairns,et al. Mutation selection and the natural history of cancer , 1975, Nature.
[60] R. Sachs,et al. Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells. , 2005, Cancer genetics and cytogenetics.
[61] From aneuploidy to cancer: The evolution of a new species? , 2012, Journal of Biosciences.
[62] D. Felsher,et al. Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs. , 2013, Advances in experimental medicine and biology.
[63] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[64] D. García-Olmo,et al. Transformation of non-tumor host cells during tumor progression: theories and evidence , 2012, Expert opinion on biological therapy.
[65] Batoul Y. Abdallah,et al. Genome chaos: Survival strategy during crisis , 2014, Cell cycle.
[66] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[67] L. Chung,et al. Spontaneous Cancer-Stromal Cell Fusion as a Mechanism of Prostate Cancer Androgen-Independent Progression , 2012, PloS one.
[68] J. Belizário. The humankind genome: from genetic diversity to the origin of human diseases. , 2013, Genome.
[69] C. Mceuen. Occurrence of cancer in rats treated with oestrone. , 1938, The American journal of cancer.
[70] Y. Yamashita,et al. DNA asymmetry in stem cells – immortal or mortal? , 2013, Journal of Cell Science.
[71] Christopher R. Jones,et al. Sex increases the efficacy of natural selection in experimental yeast populations , 2005, Nature.
[72] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[73] G. Barry,et al. The emerging role of RNA and DNA editing in cancer. , 2014, Biochimica et biophysica acta.
[74] R. Noble,et al. Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation. , 1975, Cancer research.
[75] J. Settleman,et al. From Cancer Genomics to Precision Oncology—Tissue’s Still an Issue , 2014, Cell.
[76] Wei Duan,et al. Cancer stem cells: A contentious hypothesis now moving forward. , 2014, Cancer letters.
[77] G. Vereb,et al. Die hard: Are cancer stem cells the Bruce Willises of tumor biology? , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[78] M. Cragg,et al. Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal , 2013, Cancer Cell International.
[79] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[80] J. Uitto,et al. Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy. , 2012, Discovery medicine.
[81] M. Lisanti,et al. Reviewing once more the c-myc and Ras collaboration , 2011, Cell cycle.
[82] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[83] M. Lisanti,et al. c-Myc induction of programmed cell death may contribute to carcinogenesis , 2011, Cancer biology & therapy.
[84] Y. Lazebnik,et al. Cell fusion: a hidden enemy? , 2003, Cancer cell.
[85] G. Clawson. Fusion for Moving , 2013, Science.
[86] Alan Ashworth,et al. Stem cells and breast cancer: A field in transit , 2003, Nature Reviews Cancer.
[87] Kornelia Polyak,et al. Cancer Cell Phenotypes, in Fifty Shades of Grey , 2013, Science.
[88] T. Shlomi,et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence , 2013, Nature.
[89] S. Subramanian. Quantifying harmful mutations in human populations , 2012, European Journal of Human Genetics.
[90] J. Shendure,et al. Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.
[91] E. Ben-Jacob,et al. Bacterial survival strategies suggest rethinking cancer cooperativity. , 2012, Trends in microbiology.
[92] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[93] C. Lineweaver,et al. Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors , 2011, Physical biology.
[94] E. Swisher,et al. Secondary mutations of BRCA1/2 and drug resistance , 2011, Cancer science.
[95] J. M. Nicholson,et al. Is carcinogenesis a form of speciation? , 2011, Cell cycle.
[96] Mark D Vincent,et al. Cancer: beyond speciation. , 2011, Advances in cancer research.
[97] Batoul Y. Abdallah,et al. Evolutionary mechanisms and diversity in cancer. , 2011, Advances in cancer research.
[98] D. Schwarz,et al. A NOVEL PREFERENCE FOR AN INVASIVE PLANT AS A MECHANISM FOR ANIMAL HYBRID SPECIATION , 2007, Evolution; international journal of organic evolution.
[99] E. Jaffe,et al. Horizontal Transmission of Malignancy: In-Vivo Fusion of Human Lymphomas with Hamster Stroma Produces Tumors Retaining Human Genes and Lymphoid Pathology , 2013, PloS one.
[100] R. Noble. Sex steroids as a cause of adenocarcinoma of the dorsal prostate in Nb rats, and their influence on the growth of transplants. , 1977, Oncology.
[101] A. Hidalgo-Miranda,et al. Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model , 2012, PloS one.
[102] M. Blagosklonny,et al. Molecular theory of cancer , 2005, Cancer biology & therapy.
[103] Henry H. Heng,et al. Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution , 2013, Cancer and Metastasis Reviews.
[104] P. Johnston,et al. Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.
[105] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[106] Philip Campbell,et al. Presenting ENCODE , 2012, Nature.
[107] T. Seyfried,et al. On the origin of cancer metastasis. , 2013, Critical reviews in oncogenesis.
[108] L. Becks,et al. Higher rates of sex evolve in spatially heterogeneous environments , 2010, Nature.
[109] D. Grignon,et al. Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer. , 2007, Histology and histopathology.
[110] C. Zimmer. Origins. On the origin of sexual reproduction. , 2009, Science.
[111] Meital Oren-Suissa,et al. Evolution of programmed cell fusion: Common mechanisms and distinct functions , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.
[112] Kavya Rakhra,et al. Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction , 2011, Proceedings of the National Academy of Sciences.
[113] Dean W. Felsher,et al. Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas , 2008, PloS one.
[114] R T Prehn,et al. Cancers beget mutations versus mutations beget cancers. , 1994, Cancer research.
[115] P. Vineis,et al. The population dynamics of cancer: a Darwinian perspective. , 2006, International journal of epidemiology.
[116] R. Noble. Production of Nb rat carcinoma of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen. , 1980, Cancer research.
[117] J. Cairns,et al. Cancer and the Immortal Strand Hypothesis , 2006, Genetics.
[118] R. Hirschhorn. In vivo reversion to normal of inherited mutations in humans , 2003, Journal of medical genetics.
[119] Adrian Carr,et al. Biochemical Diversification through Foreign Gene Expression in Bdelloid Rotifers , 2012, PLoS genetics.